Market Overview

10 Biggest Price Target Changes For Wednesday

Share:
  • H.C. Wainwright lowered Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) price target from $10 to $3.5. Diffusion Pharmaceuticals shares closed at $0.41 on Tuesday.
  • Citigroup raised the price target for Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) from $25 to $39. Dicerna Pharmaceuticals shares closed at $26.35 on Tuesday.
  • Buckingham lifted the price target for CarMax, Inc (NYSE: KMX) from $96 to $102. CarMax shares closed at $98.90 on Tuesday.
  • Morgan Stanley lifted the price target on Applied Materials, Inc. (NASDAQ: AMAT) from $61 to $68. Applied Materials closed at $60.79 on Tuesday.
  • Bank of America cut the price target on FedEx Corporation (NYSE: FDX) from $170 to $163. FedEx closed at $163.23 on Tuesday.
  • Wells Fargo raised Leidos Holdings Inc (NYSE: LDOS) price target from $95 to $102. Leidos shares closed at $91.53 on Tuesday.
  • UBS lowered the price target for Heico Corp (NYSE: HEI) from $121 to $115. Heico shares closed at $120.67 on Tuesday.
  • Credit Suisse boosted Southern Co (NYSE: SO) price target from $60 to $64. Southern shares closed at $63.70 on Tuesday.
  • Cantor Fitzgerald raised the price target for Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) from $159 to $176. Alnylam Pharmaceuticals shares closed at $116.55 on Tuesday.
  • JP Morgan cut the price target for Macerich Co (NYSE: MAC) from $40 to $34. Macerich shares closed at $25.95 on Tuesday.

Posted-In: Price Target ChangesPrice Target Pre-Market Outlook Analyst Ratings

 

Related Articles (ALNY + AMAT)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com